June 2015 PMID 25897793

Traditional Chinese lipid-lowering agent red yeast rice results in significant LDL reduction but safety is uncertain - a systematic review and meta-analysis.

Maaike C Gerards, Ruben J Terlou, Huixin Yu, C H W Koks, V E A Gerdes

Mentions

23
Peak: 6 in Mar 2024
across 3 sources since Mar 2024

Extended reach

47,425
potential audience

Total likes

879

Video views

33,354

Mentions per month

Mar 2024 – Oct 2025

Where it's discussed

  • News14 articles
  • X / Twitter7 posts
  • YouTube2 videos

AI synopsis

What people are saying

Discussions reflect a cautious curiosity, with some posts highlighting the LDL-lowering benefits of red yeast rice, such as 'significant LDL decrease,' while others question safety and call for more research, evidenced by phrases like 'safety is uncertain' and 'more reliable studies needed.' The tone oscillates between cautious optimism and concern, demonstrating moderate engagement driven by safety considerations and potential benefits.

AgreementNeither agree nor disagree

The discussions show a neutral stance overall, with some acknowledging LDL reduction but expressing caution due to safety concerns.

InterestModerate interest

Participants are somewhat interested, focusing on safety and effectiveness, indicating a moderate level of engagement with the topic.

EngagementModerate engagement

Respondents are engaging by sharing opinions and aspects of the study, though not deeply analyzing methodologies or broader implications.

ImpactNeutral impact

The collective discussion suggests limited immediate impact, mainly raising questions about safety rather than driving urgent change or adoption.

Abstract in brief

  • Traditional Chinese red yeast rice (RYR) significantly reduces LDL cholesterol levels, with an average decrease of around 0.102 mmol/L, and its effect is comparable to statin therapy.
  • The safety of RYR is uncertain; most studies had low quality in safety assessments, but the incidence of liver and kidney injury was low (about 0.5%) and similar to placebo or control groups.
  • More reliable studies are needed to confirm RYR’s safety profile, but it could be a safe and effective option for patients who cannot tolerate statins.

Top posts

Most liked on X and Bluesky
真理波
@MDPHD_mouchoi · X

紅麹は大幅なLDL減少をもたらすが、安全性は不確かである - 体系的レビューとメタ分析 https://t.co/0bVZHCDORu 急性腎不全および肝不全の推定原因としての紅麹 https://t.co/VBca3iG0gm

Mar 27, 2024 · 16 likes · 6 shares · 3,023 followers View post →
seb
@jensenjeans · X

https://t.co/6aXS58HZVV

Oct 5, 2025 · 3 likes · 3,532 followers View post →
aki_panda_aki
@aki_panda_aki · X

RT @MDPHD_mouchoi: 紅麹は大幅なLDL減少をもたらすが、安全性は不確かである - 体系的レビューとメタ分析 https://t.co/0bVZHCDORu 急性腎不全および肝不全の推定原因としての紅麹 https://t.co/VBca3iG0gm

Mar 28, 2024 · 6 shares · 2,558 followers View post →
Taku_F / Moderna
@TakumiFukagawa · X

RT @MDPHD_mouchoi: 紅麹は大幅なLDL減少をもたらすが、安全性は不確かである - 体系的レビューとメタ分析 https://t.co/0bVZHCDORu 急性腎不全および肝不全の推定原因としての紅麹 https://t.co/VBca3iG0gm

Mar 28, 2024 · 6 shares · 1,886 followers View post →
しらお いなめ
@inameshirao · X

RT @MDPHD_mouchoi: 紅麹は大幅なLDL減少をもたらすが、安全性は不確かである - 体系的レビューとメタ分析 https://t.co/0bVZHCDORu 急性腎不全および肝不全の推定原因としての紅麹 https://t.co/VBca3iG0gm

Mar 28, 2024 · 6 shares · 1,286 followers View post →
狢堂主人@富民厚防
@Mujinado · X

RT @MDPHD_mouchoi: 紅麹は大幅なLDL減少をもたらすが、安全性は不確かである - 体系的レビューとメタ分析 https://t.co/0bVZHCDORu 急性腎不全および肝不全の推定原因としての紅麹 https://t.co/VBca3iG0gm

Mar 27, 2024 · 6 shares · 1,024 followers View post →

All mentions

seb
@jensenjeans · X

https://t.co/6aXS58HZVV

Oct 5, 2025 · 3 likes · 3,532 followers View post →
Taku_F / Moderna
@TakumiFukagawa · X

RT @MDPHD_mouchoi: 紅麹は大幅なLDL減少をもたらすが、安全性は不確かである - 体系的レビューとメタ分析 https://t.co/0bVZHCDORu 急性腎不全および肝不全の推定原因としての紅麹 https://t.co/VBca3iG0gm

Mar 28, 2024 · 6 shares · 1,886 followers View post →
aki_panda_aki
@aki_panda_aki · X

RT @MDPHD_mouchoi: 紅麹は大幅なLDL減少をもたらすが、安全性は不確かである - 体系的レビューとメタ分析 https://t.co/0bVZHCDORu 急性腎不全および肝不全の推定原因としての紅麹 https://t.co/VBca3iG0gm

Mar 28, 2024 · 6 shares · 2,558 followers View post →
しらお いなめ
@inameshirao · X

RT @MDPHD_mouchoi: 紅麹は大幅なLDL減少をもたらすが、安全性は不確かである - 体系的レビューとメタ分析 https://t.co/0bVZHCDORu 急性腎不全および肝不全の推定原因としての紅麹 https://t.co/VBca3iG0gm

Mar 28, 2024 · 6 shares · 1,286 followers View post →
ガンボーイ➕
@gun_koma_nsr · X

RT @MDPHD_mouchoi: 紅麹は大幅なLDL減少をもたらすが、安全性は不確かである - 体系的レビューとメタ分析 https://t.co/0bVZHCDORu 急性腎不全および肝不全の推定原因としての紅麹 https://t.co/VBca3iG0gm

Mar 27, 2024 · 6 shares · 691 followers View post →
狢堂主人@富民厚防
@Mujinado · X

RT @MDPHD_mouchoi: 紅麹は大幅なLDL減少をもたらすが、安全性は不確かである - 体系的レビューとメタ分析 https://t.co/0bVZHCDORu 急性腎不全および肝不全の推定原因としての紅麹 https://t.co/VBca3iG0gm

Mar 27, 2024 · 6 shares · 1,024 followers View post →
真理波
@MDPHD_mouchoi · X

紅麹は大幅なLDL減少をもたらすが、安全性は不確かである - 体系的レビューとメタ分析 https://t.co/0bVZHCDORu 急性腎不全および肝不全の推定原因としての紅麹 https://t.co/VBca3iG0gm

Mar 27, 2024 · 16 likes · 6 shares · 3,023 followers View post →